EP Vantage • May. 10, 2011
There are no Related articles on DMYDF.
There are no Transcripts on DMYDF.
We currently have no Breaking News on this stock.
DMYDF vs. ETF Alternatives
DiaDiamyd Medical is a Swedish biotech company focusing on the development of pharmaceuticals for the treatment of pain, neuropathy and diabetes. The development projects for the treatment of chronic pain and neuropathy uses the Company?s patented NTDDS (Nerve Targeting Drug Delivery System)... More
Other News & PR